- Tools for journalists
- Join us
Most of the drugs sold worldwide come from India and China, where production is cheapest. As a result, Europe’s supply of medicines is in the hands of a few companies.
The COVID-19 outbreak has revived fears over acute drug shortages in Europe, sparking calls to repatriate the production of pharmaceutical ingredients from China. But rebuilding capacity would take years, if it were even possible.
Locked for years in digital alienation, the EU has set a new standard on data protection and privacy, wrestling back some control from Silicon Valley. But with the coming of age of AI-based applications, Chinese firms strive in turn for a piece of the colony.
A report by the NGO Transport and Environment promises a six-fold increase in Europe’s electric-car production by 2025. But Chinese producers continue to dominate the sector.
As talks for the reunification of Cyprus look to get back underway following last year’s failed UN-led negotiations, there may be more at the negotiating table than some had bargained for this time around.